BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8061421)

  • 1. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.
    Niendorf HP; Laniado M; Semmler W; Schörner W; Felix R
    AJNR Am J Neuroradiol; 1987; 8(5):803-15. PubMed ID: 2823588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 5. The application of contrast agents in the evaluation of neoplasms of the central nervous system.
    Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Mayr NA
    Top Magn Reson Imaging; 1992 Sep; 4(4):1-6. PubMed ID: 1419031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R; Melloni P
    AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
    [No Abstract]   [Full Text] [Related]  

  • 8. MR of corticotropin-secreting pituitary microadenomas.
    Colombo N; Loli P; Vignati F; Scialfa G
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1591-5. PubMed ID: 7985584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
    Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
    Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of bolus and constant infusion methods of gadolinium administration in MR angiography.
    Sze G; Goldberg SN; Kawamura Y
    AJNR Am J Neuroradiol; 1994 May; 15(5):909-12. PubMed ID: 8059659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MR imaging of the pituitary gland with fast spin-echo technique.
    Davis WL; Lee JN; King BD; Harnsberger HR
    J Magn Reson Imaging; 1994; 4(3):509-11. PubMed ID: 8061456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
    Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
    Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast dosage in the neuroimaging of brain tumors. Principles and indications.
    Maley JE; Yuh WT
    Magn Reson Imaging Clin N Am; 1998 Feb; 6(1):113-24. PubMed ID: 9449743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 17. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.